Nuzenio

Gpcr

Gpcr news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Structure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:32:25 GMT GPCR SWOT Analysis: Financial Challenges and Opportunities Revealed in 10-Q Filing - GuruFocusGuruFocus · Sat, 08 Aug 2026 06:32:50 GMT Structure Therapeutics (GPCR) awards options and RSUs to its CCO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:09:08 GMT Structure Therapeutics Inc. (GPCR) files initial Form 3 for CCO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:07:09 GMT GPCR: Net loss widened to $182.1M as R&D spending surged; cash reserves support operations through 2028 - TradingViewTradingView · Thu, 06 Aug 2026 20:30:41 GMT Structure Therapeutics (Nasdaq: GPCR) reports $182.1M H1 loss and $1.34B cash - Stock TitanStock Titan · Thu, 06 Aug 2026 20:29:54 GMT FMR LLC discloses major 13.2% GPCR stake in Structure Therapeutics Inc (GPCR) - Stock TitanStock Titan · Thu, 06 Aug 2026 14:41:56 GMT Structure Therapeutics (GPCR) CSO sells 3,939 ADS after option exercise - Stock TitanStock Titan · Wed, 05 Aug 2026 20:50:08 GMT

Timeline

Sat, 08 Aug 2026 17:32:25 GMTStructure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial - simplywall.st

Sat, 08 Aug 2026 06:32:50 GMTGPCR SWOT Analysis: Financial Challenges and Opportunities Revealed in 10-Q Filing - GuruFocus

Fri, 07 Aug 2026 20:09:08 GMTStructure Therapeutics (GPCR) awards options and RSUs to its CCO - Stock Titan

Fri, 07 Aug 2026 20:07:09 GMTStructure Therapeutics Inc. (GPCR) files initial Form 3 for CCO - Stock Titan

Thu, 06 Aug 2026 20:30:41 GMTGPCR: Net loss widened to $182.1M as R&D spending surged; cash reserves support operations through 2028 - TradingView

Thu, 06 Aug 2026 20:29:54 GMTStructure Therapeutics (Nasdaq: GPCR) reports $182.1M H1 loss and $1.34B cash - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Structure Therapeutics Inc7 live mentions Structure Therapeutics5 live mentions Stock Titan Structure4 live mentions NASDAQ4 live mentions Therapeutics3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions Yahoo Finance Singapore3 live mentions Is Up2 live mentions After Advancing Oral2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gpcr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.